CAS alerts: supply updates on Ranitidine and Theophylline

Published 29 November 2019. This may have been superseded, so check for later updates.

The MHRA has issued CAS alerts on medicine supply shortages of Ranitidine and Theophylline.

Ranitidine – Tablets, effervescent tablets, oral solutions and ranitidine injection are all expected to shortly be out of stock with no date for resupply until further notice. Read more here.

Theophylline (Slo-phyllin) – Manufacture of this product has ceased, and is anticipated to be out of stock by the end of November. Read more here